These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 10883279)

  • 1. [Expression and characterization of HIV-1 Gag p17-p24 protein].
    Li TY; Jin NY; Wang HW; Guo ZR; Fang HH; An RG; Yin Z
    Sheng Wu Gong Cheng Xue Bao; 2000 Jan; 16(1):65-8. PubMed ID: 10883279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancement of cellular and humoral immune responses to human immunodeficiency virus type 1 Gag and Pol by a G/P-92 fusion protein expressing highly immunogenic Gag p17/p24 and Pol p51 antigens.
    Kmieciak D; Bolesta E; Naito T; Gzyl J; Kaneko Y; Kozbor D
    J Hum Virol; 2001; 4(6):306-16. PubMed ID: 12082397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunization of human HIV-seronegative volunteers with recombinant p17/p24:Ty virus-like particles elicits HIV-1 p24-specific cellular and humoral immune responses.
    Martin SJ; Vyakarnam A; Cheingsong-Popov R; Callow D; Jones KL; Senior JM; Adams SE; Kingsman AJ; Matear P; Gotch FM
    AIDS; 1993 Oct; 7(10):1315-23. PubMed ID: 8267904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Morphogenic capabilities of human immunodeficiency virus type 1 gag and gag-pol proteins in insect cells.
    Hughes BP; Booth TF; Belyaev AS; McIlroy D; Jowett J; Roy P
    Virology; 1993 Mar; 193(1):242-55. PubMed ID: 8438569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of the presence of anti-protein gag antibodies as an evolution marker of HIV infection.
    Neguţ EA; Usein CR; Sfartz S; Zugun-Eloae F
    Roum Arch Microbiol Immunol; 1999; 58(2):131-46. PubMed ID: 11845452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of HIV-1 proteins in Escherichia coli by a modified expression vector and their one-step purification.
    Cheynet V; Verrier B; Mallet F
    Protein Expr Purif; 1993 Oct; 4(5):367-72. PubMed ID: 8251747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibody recognition of synthetic peptides mimicking immunodominant regions of HIV-1 p24 and p17 proteins.
    Lottersberger J; Salvetti JL; Beltramini LM; Tonarelli G
    Rev Argent Microbiol; 2004; 36(4):151-7. PubMed ID: 15786866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of HIV-1 replication in primary human T cells transduced with an intracellular anti-HIV-1 p17 antibody gene.
    Tewari D; Notkins AL; Zhou P
    J Gene Med; 2003 Mar; 5(3):182-9. PubMed ID: 12666184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fine specificity of IgG subclass response to group antigens in HIV-1-infected patients.
    Broliden PA; Morfeldt-Månsson L; Rosen J; Jondal M; Wahren B
    Clin Exp Immunol; 1989 May; 76(2):216-21. PubMed ID: 2503275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decline in CTL and antibody responses to HIV-1 p17 and p24 antigens in HIV-1-infected hemophiliacs irrespective of disease progression. A 5-year follow-up study.
    O'Toole CM; Lowdell MW; Chargelegue D; Colvin BT
    AIDS Res Hum Retroviruses; 1992 Aug; 8(8):1361-8. PubMed ID: 1281655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A synthetic HIV-1 protease inhibitor with antiviral activity arrests HIV-like particle maturation.
    Dis Markers; 1990; 8(3):162-3. PubMed ID: 2125537
    [No Abstract]   [Full Text] [Related]  

  • 12. HIV-1 gag proteins in virions and in infected cell fractions.
    Sharova NK; Grigor'ev VB; Bukrinskaya AG
    Biomed Sci; 1991; 2(3):279-84. PubMed ID: 1751761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of a new dot blot assay for confirmation of human immunodeficiency virus type 1 and 2 infections using recombinant p24, gp41, gp120 and gp36 antigens.
    Ravanshad M; Sabahi F; Mahboudi F; Kazemnejad A
    Saudi Med J; 2006 Jan; 27(1):31-6. PubMed ID: 16432590
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Formation of virus-like particles by HIV-1 Gag proteins, expressed by a recombinant vaccinia virus].
    Vzorov AN; Tentsov IuIu; Grigor'ev VB; Shulenin SA; Garaev MM; Bogdan OP; Bukrinskaia AG
    Mol Biol (Mosk); 1990; 24(6):1666-74. PubMed ID: 2094814
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neutralization of human immunodeficiency virus type 1 (HIV-1) with antibody from carriers' plasma against HIV-1 protein p17.
    Kageyama S; Katsumoto T; Taniguchi K; Ismail SI; Shimmen T; Sasao F; Gao M; Owatari S; Wakamiya N; Tsuchie H; Ueda S; Shiraki K; Kurimura T
    Acta Virol; 1996 Sep; 40(4):195-200. PubMed ID: 9014009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimal conditions of immune complex transfer enzyme immunoassays for antibody IgGs to HIV-1 using recombinant p17, p24, and reverse transcriptase as antigens.
    Hashida S; Ishikawa S; Hashinaka K; Nishikata I; Oka S; Shimada K; Saito A; Takamizawa A; Shinagawa H; Ishikawa E
    J Clin Lab Anal; 1998; 12(2):98-107. PubMed ID: 9524294
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of recombinant influenza A virus as a vector for HIV-1 p17Gag.
    de Goede AL; Boers PH; Dekker LJ; Osterhaus AD; Gruters RA; Rimmelzwaan GF
    Vaccine; 2009 Sep; 27(42):5735-9. PubMed ID: 19647812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of MA internal sequences, but not of the myristylated N-terminus sequence, on the budding site of HIV-1 Gag protein.
    Gallina A; Mantoan G; Rindi G; Milanesi G
    Biochem Biophys Res Commun; 1994 Nov; 204(3):1031-8. PubMed ID: 7980574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Group- and type-specific antibodies to the gag-gene protein p26 of the human immunodeficiency virus immunological type 2 in infected patients].
    Kliushnik SIu; Selimova LM; Veselovskaia TV; Zaĭdes VM
    Biull Eksp Biol Med; 1991 Mar; 111(3):283-4. PubMed ID: 2054505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of HIV-2 Gag and Env antigens in E. coli.
    Ulrich R; Siakkou H; Krüger DH
    Acta Virol; 1992 Oct; 36(5):491. PubMed ID: 1364028
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.